Cargando…

Cytokine response in severe sepsis: predicting and modelling the course of illness

Detalles Bibliográficos
Autores principales:	Malaska, J, Kratochvil, M, Kyr, M, Jabandziev, P, Otevrel, F, Muriova, K, Fedora, M, Sramek, V, Michalek, J, Sevcik, P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934342/ http://dx.doi.org/10.1186/cc8269

Ejemplares similares

Critically ill patients with cancer and sepsis: clinical course and prognostic factors
por: Rabello, LSCF, et al.
Publicado: (2011)

The time course of adrenocortical hormones and cytokines in sepsis and/or septic shock
por: Dimopoulou, I, et al.
Publicado: (2005)

Modeling effect of the septic condition and trauma on C-reactive protein levels in children with sepsis: a retrospective study
por: Kyr, Michal, et al.
Publicado: (2007)

Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis
por: Jabandziev, Petr, et al.
Publicado: (2014)

Cytokine gene expression profiling identifies distinct patterns in severe sepsis
por: Sarveswaran, J, et al.
Publicado: (2012)

Hyperphosphorylated neurofilament NF-H, S100β and NSE as indicators of severity of brain injury in children
por: Žurek, J, et al.
Publicado: (2010)

Tissue microdialysis in critically ill septic patients: associations with sepsis severity and mortality
por: Theodorakopoulou, M, et al.
Publicado: (2010)

Influence of severity of illness on the effects of eritoran tetrasodium (E5564), a TLR4 antagonist, in patients with severe sepsis
por: Opal, SM, et al.
Publicado: (2009)

Influence of medical emergency team call system on critically ill patients
por: Pavlik, M, et al.
Publicado: (2009)

Trefoil factor 3 as a marker of intestinal cell damage during sepsis
por: Žurek, Jiří, et al.
Publicado: (2015)

Impact of oncologic pathology (OP) in the evolution of severe sepsis (SS) in the critically ill patients (CIP)
por: Ruiz Moreno, J, et al.
Publicado: (2015)

Chronically critically ill patients: different behavior in severe sepsis and septic shock?
por: Prevedello, DH, et al.
Publicado: (2015)

Sustained high-efficiency daily diafiltration using a cytokine-adsorbing membrane in the treatment of patients with severe sepsis
por: Nishida, O, et al.
Publicado: (2011)

Serial estimation of cytokine markers and their correlation with mortality in elderly patients with sepsis
por: Bhanot, R, et al.
Publicado: (2010)

Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
por: de Anda, G Vazquez, et al.
Publicado: (2005)

Association of initial intracellular signalling pathway and cytokine level with early mortality in severe sepsis patients
por: Lie, KC, et al.
Publicado: (2014)

Effect of protective ventilation on organ-specific cytokine production in an experimental postoperative sepsis model
por: Sperber, J, et al.
Publicado: (2013)

A Study of Pro-Bnp Compared to Procalcitonin in Patient With Severe Sepsis As a Marker of Diagnosis of Sepsis in Critically Ill Patients
por: Elshrief, SR, et al.
Publicado: (2015)

The endothelial glycocalyx degenerates with increasing sepsis severity
por: Köhler, M, et al.
Publicado: (2011)

Systemic symptoms as markers for severity in sepsis
por: Edman-Wallér, J, et al.
Publicado: (2015)

Epidemiology of severe sepsis in India
por: Todi, S, et al.
Publicado: (2007)

Epidemiology of severe sepsis in India
por: Chatterjee, S, et al.
Publicado: (2009)

Subcutaneous glucose monitoring in patients with severe sepsis
por: Mader, JK, et al.
Publicado: (2007)

Urinary and plasma cytokines in the critically ill
por: Adam, Z, et al.
Publicado: (2006)

Distribution of critically ill patients (CIP) with severe sepsis (SS) according to the major diagnostic categories (MDC) of the diagnosis-related groups (DRG)
por: Ruiz Moreno, J, et al.
Publicado: (2015)

Changes in health-related quality of life in severe sepsis
por: Hofhuis, J, et al.
Publicado: (2005)

Therapy of compartmentalization of the proinflammatory and anti-inflammatory cytokines in sepsis
por: Grigoryev, EG
Publicado: (2010)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Improving identification of severe sepsis by junior doctors: an observational study
por: Slattery, M, et al.
Publicado: (2009)

Epidemiology of severe sepsis in India: an update
por: Todi, S, et al.
Publicado: (2010)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Prospective immune profiling in critically ill adults: before, during and after severe sepsis and septic shock
por: Layios, N
Publicado: (2015)

Association between DNA haplogroups and severe sepsis in patients who underwent major surgery
por: Gomez, E, et al.
Publicado: (2014)

Induction of severe Staphylococcus aureus sepsis in pigs
por: Iburg, TM, et al.
Publicado: (2009)

Outcome and prognostic factors in critically ill cancer patients with diagnosis of sepsis in the ICU
por: Filho, R Kalil, et al.
Publicado: (2009)

Innate immunity and inflammation in sepsis: mechanisms by which acute ethanol exposure alters the course of sepsis and the effect to TLR4 signaling
por: Jan, B, et al.
Publicado: (2010)

Early course of microcirculatory perfusion in the eye and digestive tract during experimental sepsis
por: Pranskunas, A, et al.
Publicado: (2012)

Peri-mortem and ante-mortem haemodynamic profile of severe sepsis/septic shock
por: Marcelino, P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_78kp5hjic6pq60umqabn3thub6